Delhi HC Clears Zydus Biosimilar: A Game-Changer for Affordable Cancer Care in India
In a landmark decision that could transform oncology care in India, the Delhi High Court has cleared the way for Zydus Lifesciences to market its trastuzumab biosimilar—a move expected to drastically reduce the cost of life-saving breast cancer treatment for thousands of patients.





